Human cardiac tissue in a microperfusion chamber simulating extracorporeal circulation - ischemia and apoptosis studies

Journal of Cardiothoracic Surgery

Volumn 5, Issue 1, 2010, Pages

  Usta, Engin ^a   Renovanz, Mirijam ^a   Mustafi, Migdat ^a   Ziemer, Gerhard ^a   Aebert, Hermann ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM; CARBAZOLE DERIVATIVE; CARVEDILOL; FURA 2; PROPANOLAMINE DERIVATIVE;

ANALYSIS OF VARIANCE; APOPTOSIS; ARTICLE; BIOPSY; CELL ADHESION; DRUG EFFECT; ENZYME IMMUNOASSAY; HEART ARREST; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HUMAN; IN VITRO STUDY; METABOLISM; METHODOLOGY; PATHOLOGY; PHYSIOLOGY; REPERFUSION INJURY;

ADRENERGIC BETA-ANTAGONISTS; ANALYSIS OF VARIANCE; APOPTOSIS; BIOPSY; CALCIUM; CARBAZOLES; CELL ADHESION; FURA-2; HEART ARREST, INDUCED; HUMANS; IMMUNOENZYME TECHNIQUES; MYOCARDIAL ISCHEMIA; MYOCYTES, CARDIAC; PROPANOLAMINES; REPERFUSION INJURY;

EID: 76649145645     PISSN: None     EISSN: 17498090     Source Type: Journal    
DOI: 10.1186/1749-8090-5-3     Document Type: Article

References (32)

1. Grisham MB, Granger DN, Lefer DJ. Modulation of leukocyte-endothelial interactions by reactive metabolites of oxygen and nitrogen: relevance to ischemic heart disease. Free Radic Biol Med 1998, 25:404-433. 10.1016/S0891-5849(98)00094-X, 9741579.
2. Aebert H, Kirchner S, Keyser A, Birnbaum DE, Holler E, Andreesen R, et al. Endothelial apoptosis is induced by serum of patients after cardiopulmonary bypass. Eur J Cardiothorac Surg 2000, 18:589-593. 10.1016/S1010-7940(00)00565-0, 11053822.
3. Bai CX, Namekata I, Kurokawa J, Tanaka H, Shigenobu K, Furukawa T. Role of nitric oxide in Ca2+ sensitivity of the slowly activating delayed rectifier K+ current in cardiac myocytes. Circ Res 2005, 96:64-72. 10.1161/01.RES.0000151846.19788.E0, 15569827.
4. Murriel CL, Churchill E, Inagaki K, Szweda LI, Mochly-Rosen D. Protein kinase Cdelta activation induces apoptosis in response to cardiac ischemia and reperfusion damage: a mechanism involving BAD and the mitochondria. J Biol Chem 2004, 279:47985-47991. 10.1074/jbc.M405071200, 15339931.
5. Ak K, Akgun S, Tecimer T, Isbir CS, Civelek A, Tekeli A, et al. Determination of histopathologic risk factors for postoperative atrial fibrillation in cardiac surgery. Ann Thorac Surg 2005, 79:1970-1975. 10.1016/j.athoracsur.2004.12.029, 15919294.
6. Khoynezhad A, Jalali Z, Tortolani AJ. A synopsis of research in cardiac apoptosis and its application to congestive heart failure. Tex Heart Inst J 2007, 34:352-359. 1995053, 17948087.
7. Chanani NK, Cowan DB, Takeuchi K, Poutias DN, Garcia LM, del Nido PJ, et al. Differential effects of amrinone and milrinone upon myocardial inflammatory signaling. Circulation 2002, 106:1284-1289.
8. Azuma M, Yamane M, Tachibana K, Morimoto Y, Kemmotsu O. Effects of epinephrine and phosphodiesterase III inhibitors on bupivacaine-induced myocardial depression in guinea-pig papillary muscle. Br J Anaesth 2003, 90:66-71. 10.1093/bja/90.1.66, 12488382.
9. Fukutomi T, Satoh K, Ogoshi S, Ichihara K. Effects of pimobendan and EGIS 9377, cardiotonic agents, and OG-VI, a nucleoside-nucleotide mixture, administered during reperfusion after ischemia on stunned myocardium in dogs. Coron Artery Dis 2000, 11:83-90. 10.1097/00019501-200002000-00014, 10715811.
10. Goldstein SM, Nelson RL, McConnell DH, Buckberg GD. Effects of conventional hypothermic ischemic arrest and pharmacological arrest on myocardial supply/demand balance during aortic cross-clamping. Ann Thorac Surg 1977, 23:520-528.
11. Tsien RY, Rink TJ, Poenie M. Measurement of cytosolic free Ca2+ in individual small cells using fluorescence microscopy with dual excitation wavelengths. Cell Calcium 1985, 6:145-157. 10.1016/0143-4160(85)90041-7, 3874696.
12. Schwarz ER, Kersting PH, Reffelmann T, Meven DA, Al Dashti R, Skobel EC, et al. Cardioprotection by Carvedilol: antiapoptosis is independent of beta-adrenoceptor blockage in the rat heart. J Cardiovasc Pharmacol Ther 2003, 8:207-215. 10.1177/107424840300800306, 14506546.
13. Tewari M, Quan LT, O'Rourke K, Desnoyers S, Zeng Z, Beidler DR, et al. Yama/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell 1995, 81:801-809. 10.1016/0092-8674(95)90541-3, 7774019.
14. Ghosh S, Ng LL, Talwar S, Squire IB, Galinanes M. Cardiotrophin-1 protects the human myocardium from ischemic injury. Comparison with the first and second window of protection by ischemic preconditioning. Cardiovasc Res 2000, 48:440-447. 10.1016/S0008-6363(00)00186-3, 11090839.
15. Miyamoto S, Howes AL, Adams JW, Dorn GW, Brown JH. Ca2+ dysregulation induces mitochondrial depolarization and apoptosis: role of Na+/Ca2+ exchanger and AKT. J Biol Chem 2005, 280:38505-38512. 10.1074/jbc.M505223200, 16061478.
16. Lowe H, Jacobsohn E. Protection of the hypoxic myocardium by the bispyridine derivatives AWD 122-14 and milrinone: studies on isolated, working right rabbit hearts. Pharmazie 1992, 47:452-455.
17. Hilfiker-Kleiner D, Hilfiker A, Fuchs M, Kaminski K, Schaefer A, Schieffer B, et al. Signal transducer and activator of transcription 3 is required for myocardial capillary growth, control of interstitial matrix deposition, and heart protection from ischemic injury. Circ Res 2004, 95:187-195. 10.1161/01.RES.0000134921.50377.61, 15192020.
18. Groholm T, Finckenberg P, Palojoki E, Saraste A, Backlund T, Eriksson A, et al. Cardioprotective effects of vasopeptidase inhibition vs. angiotensin type 1-receptor blockade in spontaneously hypertensive rats on a high salt diet. Hypertens Res 2004, 27:609-618. 10.1291/hypres.27.609, 15492481.
19. Hickson-Bick DL, Sparagna GC, Buja LM, McMillin JB. Palmitate-induced apoptosis in neonatal cardiomyocytes is not dependent on the generation of ROS. Am J Physiol Heart Circ Physiol 2002, 282:H656-H664.
20. Granville DJ, Tashakkor B, Takeuchi C, Gustafsson AB, Huang C, Sayen MR, et al. Reduction of ischemia and reperfusion-induced myocardial damage by cytochrome P450 inhibitors. Proc Natl Acad Sci USA 2004, 101:1321-1326. 10.1073/pnas.0308185100, 337051, 14734800.
21. Kaiser RA, Bueno OF, Lips DJ, Doevendans PA, Jones F, Kimball TF, et al. Targeted inhibition of p38 mitogen-activated protein kinase antagonizes cardiac injury and cell death following ischemia-reperfusion in vivo. J Biol Chem 2004, 279:15524-15530. 10.1074/jbc.M313717200, 14749328.
22. Ren J, Wold LE, Natavio M, Ren BH, Hannigan JH, Brown RA. Influence of prenatal alcohol exposure on myocardial contractile function in adult rat hearts: role of intracellular calcium and apoptosis. Alcohol Alcohol 2002, 37:30-37.
23. Gonzalez A, Lopez B, Ravassa S, Querejeta R, Larman M, Diez J, et al. Stimulation of cardiac apoptosis in essential hypertension: potential role of angiotensin II. Hypertension 2002, 39:75-80. 10.1161/hy0102.100788, 11799082.
24. DeBiasi RL, Robinson BA, Sherry B, Bouchard R, Brown RD, Rizeq M, et al. Caspase inhibition protects against reovirus-induced myocardial injury in vitro and in vivo. J Virol 2004, 78:11040-11050. 10.1128/JVI.78.20.11040-11050.2004, 521817, 15452224.
25. Los M, Mozoluk M, Ferrari D, Stepczynska A, Stroh C, Renz A, et al. Activation and caspase-mediated inhibition of PARP: a molecular switch between fibroblast necrosis and apoptosis in death receptor signaling. Mol Biol Cell 2002, 13:978-988. 10.1091/mbc.01-05-0272, 99613, 11907276.
26. Fischer UM, Klass O, Stock U, Easo J, Geissler HJ, Fischer JH, et al. Cardioplegic arrest induces apoptosis signal-pathway in myocardial endothelial cells and cardiac myocytes. Eur J Cardiothorac Surg 2003, 23:984-990. 10.1016/S1010-7940(03)00113-1, 12829076.
27. Okafor CC, Perreault-Micale C, Hajjar RJ, Lebeche D, Skiroman K, Jabbour G, et al. Chronic treatment with carvedilol improves ventricular function and reduces myocyte apoptosis in an animal model of heart failure. BMC Physiol 2003, 212709, 12873352.
28. Kawai K, Qin F, Shite J, Mao W, Fukuoka S, Liang CS. Importance of antioxidant and antiapoptotic effects of beta-receptor blockers in heart failure therapy. Am J Physiol Heart Circ Physiol 2004, 287:H1003-H1012. 10.1152/ajpheart.00797.2003, 15105169.
29. Asanuma H, Minamino T, Sanada S, Takashima S, Ogita H, Ogai A, et al. Beta-adrenoceptor blocker carvedilol provides cardioprotection via an adenosine-dependent mechanism in ischemic canine hearts. Circulation 2004, 109:2773-2779. 10.1161/01.CIR.0000130917.12959.04, 15148268.
30. Wang R, Miura T, Harada N, Kametani R, Shibuya M, Fukagawa Y, et al. Pleiotropic effects of the beta-adrenoceptor blocker carvedilol on calcium regulation during oxidative stress-induced apoptosis in cardiomyocytes. J Pharmacol Exp Ther 2006, 318:45-52. 10.1124/jpet.105.099903, 16611853.
31. Amos GJ, Wettwer E, Metzger F, Li Q, Himmel HM, Ravens U. Differences between outward currents of human atrial and subepicardial ventricular myocytes. J Physiol 1996, 491:31-50. 1158757, 9011620.
32. Book WM. Carvedilol: a nonselective beta blocking agent with antioxidant properties. Congest Heart Fail 2002, 8:173-177. 10.1111/j.1527-5299.2002.00718.x, 12045386.